Previous Article | Next Article ![]()
Journal of Virology, September 2007, p. 9088-9099, Vol. 81, No. 17
0022-538X/07/$08.00+0 doi:10.1128/JVI.02703-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Christophe Nicot,1,
Anthony Adams,2
Valerio W. Valeri,1
Lawrence E. Samelson,3 and
Genoveffa Franchini1*
Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland 20892-5065,1 Experimental Immunology Branch, National Cancer Institute, 10/4B36, Bethesda, Maryland 20892,2 Laboratory of Cellular and Molecular Biology, National Cancer Institute, 37/1E24, Bethesda, Maryland 208923
Received 7 December 2006/ Accepted 8 June 2007
The p12I protein of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) is a small oncoprotein that increases calcium release following protein kinase C activation by phorbol myristate acetate, and importantly, this effect is linker for activation of T cells (LAT) independent. Here, we demonstrate that p12I inhibits the phosphorylation of LAT, Vav, and phospholipase C-
1 and decreases NFAT (nuclear factor of activated T cells) activation upon engagement of the T-cell receptor (TCR) with anti-CD3 antibody. Furthermore, we demonstrate that p12I localizes to membrane lipid rafts and, upon engagement of the TCR, relocalizes to the interface between T cells and antigen-presenting cells, defined as the immunological synapse. A p12I knockout molecular clone of HTLV-1 expresses more virus upon antigen stimulation than the isogenic wild type, suggesting that, by decreasing T-cell responsiveness, p12I curtails viral expression. Thus, p12I has contrasting effects on TCR signaling: it down-regulates TCR in a LAT-dependent manner on one hand, and on the other, it increases calcium release in a LAT-independent manner. The negative regulation of T-cell activation by p12I may have evolved to minimize immune recognition of infected CD4+ T cells, to impair the function of infected cytotoxic CD8+ T cells, and to favor viral persistence in the infected host.
Published ahead of print on 20 June 2007.
Present address: Department of Cell Biology and Anatomy, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064.
Present address: Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, 3025 Wahl Hall West, 3901 Rainbow Boulevard, Kansas City, KS 66160.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»